Page 1 of Clinical Trials for "Lymphopenia", 32 Total Matches
- 1RecruitingLast Updated: March 21, 2012Condition(s): Idiopathic CD4+ T-Lymphocytopenia
- 2RecruitingLast Updated: March 20, 2012Condition(s): Idiopathic CD4+ Lymphocytopenia; Cryptococcal Meningitis; Warts
- 3CompletedLast Updated: March 3, 2008Condition(s): CD4 Lymphocytopenia; Idiopathic CD4 Positive T Lymphocytopenia
- 4RecruitingLast Updated: March 21, 2012Condition(s): Graft vs Host Disease; Healthy; Lymphopenia
- 5TerminatedLast Updated: December 21, 2011Condition(s): Thrombocytopenia; Neutropenia; Lymphopenia; Anemia
- 6CompletedLast Updated: August 23, 2010Condition(s): HIV Infections; Lymphopenia
- 7RecruitingLast Updated: March 21, 2012Condition(s): Cryptococcosis; Lymphopenia
- 8RecruitingLast Updated: February 13, 2012Condition(s): Metastatic Breast Cancer
- 9Active, not recruitingLast Updated: September 8, 2011Condition(s): Brain and Central Nervous System Tumors
- 10Active, not recruitingLast Updated: January 6, 2012Condition(s): Glioblastoma; Cytomegalovirus
- 11Not yet recruitingLast Updated: February 17, 2009Condition(s): Severe Combined Immunodeficiency; T Cell Lymphocytopenia
- 12TerminatedLast Updated: December 3, 2009Condition(s): Cardiopulmonary Bypass
- 13RecruitingLast Updated: May 14, 2012Condition(s): Breast Cancer; Lung Cancer
- 14Active, not recruitingLast Updated: September 8, 2011Condition(s): Brain and Central Nervous System Tumors
- 15CompletedLast Updated: March 25, 2010Condition(s): Melanoma (Skin)
- 16RecruitingLast Updated: June 22, 2011Condition(s): Sickle Cell Disease; Thalassemia; Anemia; Granuloma; Wiskott-Aldrich Syndrome; Chediak Higashi Syndrome; Osteopetrosis; Neutropenia; Thrombocytopenia; Hurler Disease; Niemann-Pick Disease; Fucosidosis
- 17RecruitingLast Updated: August 19, 2011Condition(s): Wiskott-Aldrich Syndrome
- 18RecruitingLast Updated: March 26, 2012Condition(s): Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Aplastic Anemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Congenital Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Paroxysmal Nocturnal Hemoglobinuria; Peripheral T-cell Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Severe Combined Immunodeficiency; Severe Congenital Neutropenia; Shwachman-Diamond Syndrome; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Waldenstrom Macroglobulinemia; Wiskott-Aldrich Syndrome
- 19CompletedLast Updated: March 23, 2012Condition(s): Wiskott-Aldrich Syndrome
- 20Active, not recruitingLast Updated: June 23, 2005Condition(s): X-Linked Agammaglobulinemia; X-Linked Hyper IgM Syndrome; Wiskott-Aldrich Syndrome; Leukocyte Adhesion Deficiency Syndrome
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Lymphopenia%22
